Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Deferred Income, Current

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Deferred Income, Current

NIAGEN BIOSCIENCE, INC. (NAGE) had Deferred Income, Current of $329.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:DeferredIncomeCurrent · last filed 2026-08-04

  • 2026-06-30: Deferred Income, Current $329.00K.
  • 2026-03-31: Deferred Income, Current $380.00K.
  • 2025-12-31: Deferred Income, Current $399.00K.
  • 2025-09-30: Deferred Income, Current $292.00K.
Period endDeferred Income, Current
2026-06-30$329.00K
10-Q · filed 2026-08-04
2026-03-31$380.00K
10-Q · filed 2026-05-06
2025-12-31$399.00K
10-Q · filed 2026-08-04
2025-09-30$292.00K
10-Q · filed 2025-11-04
2025-06-30$303.00K
10-Q · filed 2025-08-06
2025-03-31$207.00K
10-Q · filed 2025-05-07
2024-12-31$611.00K
10-K · filed 2026-03-04
2024-09-30$184.00K
10-Q · filed 2024-10-31
2024-06-30$156.00K
10-Q · filed 2024-08-07
2024-03-31$227.00K
10-Q · filed 2024-05-08
2023-12-31$195.00K
10-K · filed 2025-03-04
2023-09-30$189.00K
10-Q · filed 2023-11-08
2023-06-30$166.00K
10-Q · filed 2023-08-09
2023-03-31$148.00K
10-Q · filed 2023-05-10
2022-12-31$157.00K
10-K · filed 2024-03-06
2022-09-30$158.00K
10-Q · filed 2022-11-02
2022-06-30$173.00K
10-Q · filed 2022-08-10
2022-03-31$141.00K
10-Q · filed 2022-05-12
2021-12-31$161.00K
10-K · filed 2023-03-08
2021-09-30$175.00K
10-Q · filed 2021-11-03
2021-06-30$210.00K
10-Q · filed 2021-08-03
2020-12-31$278.00K
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87